Cytokinetics | CYTK - 债务



金融业
股票价格
USD
资产
USD 1.27B
现金及等价物
USD 129.84M
销售成本
USD 104.4M
流动资产
USD 839.47M
流动负债
USD 199.19M
债务
USD 1.28B
EBIT
USD -178.37M
EBITDA
USD -149.84M
员工
498
EPS每股收益
USD -1.67
股本和储备
USD -826.57M
销售毛利
USD 17.76M
债务利息支出
USD 30.34M
利息收入
USD 11.47M
贷款资金
USD 247.21M
市值
USD 9.25B
净收入
USD -183.03M
营业费用
USD 196.12M
营业利润
USD -178.37M
普通股股本
USD 122.27M
税前利润
USD -183.03M
销售收入
USD 19.35M
销售和管理费用
USD 91.72M
股票
USD 0
贸易债权人
USD 24.71M
应收帐款人
USD 17.76M


债务 更改 日
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Amgen USD 54.6B 17M 2025-12
Arca Biopharma USD 0 0 2025-03
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.56B 275.1M 2026-03
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 1.28B 87.39M 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Exelixis USD 173.04M 3.42M 2025-12
Geron USD 121.92M 73K 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.96B 3.11B 2025-12
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 20.33B 1.43B 2025-12